Please Wait
Applying Filters...
menu
    • menu
    Strides Pharma Science-PSE
    News
    Merck starts $1 billion Biologics Center in Delaware, US

    30 Apr 2025

    // PRESS RELEASE

    Regeneron's first-quarter results miss on lower Eylea demand

    30 Apr 2025

    // REUTERS

    FDA delays decision on Stealth' rare genetic disorder drug

    30 Apr 2025

    // REUTERS

    Data Compilation
    #PharmaFlow

    Beltapharm SPA

    Contact Supplier

    Website

    Iran Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
    Menu

    Beltapharm SPA

    EVENTS

    • Webinars & Exhibitions

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Beltapharm SPA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    Iran Expo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-05-15

    Beltapharm SPA

    City : Milano

    State :

    Country/Area : IT

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-05-15

    Beltapharm SPA

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    Iran Expo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-06-14

    Beltapharm SPA

    City : Milano

    State :

    Country/Area : IT

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-06-14

    Beltapharm SPA

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow